Provectus Pharmaceuticals Inc. (PVCT.OB) Initiates Recruitment for Phase II Efficacy Studies of its Metastatic Melanoma Treatment
Provectus Pharmaceuticals Inc. (OTCBB: PVCT) specializes in effective, affordable and minimally invasive oncology and dermatology therapies to treat diseases such…